GNPAT promotes immunosuppression in hepatocellular carcinoma by activating the plasmalogen-PPARγ pathway to drive M2 macrophage polarization
Hepatocellular carcinoma (HCC) is a major threat to human health worldwide. Its suboptimal responses to current therapies are largely attributable to the immunosuppressive tumor microenvironment (TME) that dampens the efficiency of available treatments…